Your browser doesn't support javascript.
loading
Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan.
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen.
Afiliación
  • Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.
  • Hsu KH; Institute of Biomedical Sciences, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan.
  • Tseng JS; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sect. 2, Linong St., Taipei, 112, Taiwan.
  • Yang TY; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.
  • Chen KC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.
  • Su KY; Institute of Biomedical Sciences, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan.
  • Yu SL; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, No. 155, Sect. 2, Linong St., Taipei, 112, Taiwan.
  • Chen JJW; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.
  • Chang GC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Road, Taichung, 402, Taiwan.
Target Oncol ; 18(1): 179-180, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36334173

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Taiwán
...